Emergency Egress and Information System for Persons With Vision Loss
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00262509|
Recruitment Status : Terminated (Intervention worsened performance for first 17 of 24 planned participants.)
First Posted : December 6, 2005
Results First Posted : February 11, 2014
Last Update Posted : February 11, 2014
|Condition or disease||Intervention/treatment||Phase|
|Blindness||Device: Egress Badge||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||17 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Emergency Egress and Information System for Persons With Vision Loss|
|Study Start Date :||September 2008|
|Actual Primary Completion Date :||December 2008|
|Actual Study Completion Date :||April 2009|
Experimental: Egress Badge Performance
Blind subjects are walked into a building to a specific location, and then are asked to find their way out of the building.
Device: Egress Badge
Egress Badge is worn by subjects who are asked to use the badge to exit the building. The badge indicates the direction of each exit sign on route to an exit.
No Intervention: Baseline Egress Performance
Blind subjects are walked into a building to a particular location and then asked to find their way out of the building.
- Time to Exit Building [ Time Frame: 30 minutes total, 15 minutes for each of two timed trials ]Subjects are walked into a building to a specific location and then asked to find their way out of the building. Time to Exit Building is measured. This is protocol is performed twice, and the times averaged to obtain the outcome measure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00262509
|United States, Georgia|
|Atlanta VA Medical and Rehab Center, Decatur|
|Decatur, Georgia, United States, 30033|
|Principal Investigator:||David A Ross, MSEE Med||Atlanta VA Medical and Rehab Center, Decatur|